Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S (AMGN) Price & Analysis

3 Followers

AMGN Stock Chart & Stats

C$29.07

C$0.60(2.11%)

Sep 21, 2026

―

Day’s Range― - ―

52-Week RangeC$23.95 - C$32.94

Previous CloseN/A

VolumeN/A

Average Volume (3M)3.22K

Market Cap

C$292.76B

Enterprise ValueC$76.09K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)24.2

Beta1.18

Next Earnings

Nov 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield2.54%

Share Statistics

EPS (TTM)6.04

Shares Outstanding540,632,000

10 Day Avg. Volume5,709

30 Day Avg. Volume3,219

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S News

Amgen announces ‘positive’ results from Phase 3 OASIZ 301 study

Amgen (AMGN) announced positive topline results from the Phase 3 OASIZ 301 study evaluating dazodalibep in adults with...

48m ago

AMGN

Amgen to deploy Veeva Vault CRM globally

Veeva Systems (VEEV) announced that Amgen (AMGN) plans to deploy Veeva Vault CRM globally, building on a collaboration...

7d ago

AMGN

VEEV

Amgen says FDA approves update to imdelltra Prescribing Information

Amgen (AMGN) announced that the U.S. FDA approved an update to the imdelltra Prescribing Information that substantially reduces...

8d ago

AMGN

Meta upgraded, Nvidia initiated: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

12d ago

HSBC downgrades Amgen to Hold on fair value after re-rating

HSBC analyst Morten Herholdt last night downgraded Amgen (AMGN) to Hold from Buy with a price target of...

12d ago

AMGN

Amgen downgraded to Hold from Buy at HSBC

HSBC downgraded Amgen (AMGN) to Hold from Buy with a price target of $425, down from $445. Published...

13d ago

AMGN

SpaceX initiated, Intel upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

14d ago

BBY

LMT

Amgen, AstraZeneca report Phase 3 DeLLphi-305 study met primary endpoint

Amgen (AMGN) announced results from the Phase 3 DeLLphi-305 study, which met its primary endpoint at a pre-specified...

14d ago

AZN

AMGN

AstraZeneca announces results from Phase III trial of IMFINZI, tarlatamab

Positive high-level results from a planned interim analysis of the DeLLphi-305 Phase III trial showed IMFINZI plus Amgen’s...

14d ago

AZN

AMGN

Amgen downgraded to Market Perform from Outperform at BMO Capital

BMO Capital downgraded Amgen (AMGN) to Market Perform from Outperform with an unchanged price target of $450. The...

14d ago

AMGN

Amgen: Neutral Stance Maintained as Long-Term Pipeline Offsets Near-Term Uncertainty; Price Target Reaffirmed at $405

Citi analyst Geoff Meacham maintained a Hold rating on Amgen yesterday and set a price target of $405.00....

5d ago

AMGN

Analyst Maintains Buy on Amgen, Citing Resilient Fundamentals, Strong Execution, and Late-Stage Pipeline Upside

William Blair analyst Matt Phipps has reiterated their bullish stance on AMGN stock, giving a Buy rating on...

6d ago

AMGN

Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen

William Blair analyst Matt Phipps has maintained their bullish stance on AMGN stock, giving a Buy rating today....

14d ago

AMGN

Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)

WSW, NY, August 31st, 2026, FinanceWire The drugs that rebuild bone are locked inside a channel most patients...

22d ago

LLY

NVO

AMGN FAQ

What was Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s price range in the past 12 months?

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S lowest stock price was C$23.95 and its highest was C$32.94 in the past 12 months.

What is Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s market cap?

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s market cap is C$292.76B.

When is Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s upcoming earnings report date?

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s upcoming earnings report date is Nov 03, 2026 which is in 42 days.

How were Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s earnings last quarter?

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S released its earnings results on Aug 04, 2026. The company reported C$6.044 earnings per share for the quarter.

Is Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S overvalued?

According to Wall Street analysts Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S pay dividends?

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S pays a Quarterly dividend of C$0.186 which represents an annual dividend yield of 2.54%. See more information on Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S dividends here

What is Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s EPS estimate?

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S have?

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S has 540,632,000 shares outstanding.

What happened to Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S’s price movement after its last earnings report?

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S reported an EPS of C$6.044 in its last earnings report. Following the earnings report the stock price went up 4.041%.

Which hedge fund is a major shareholder of Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S?

Currently, no hedge funds are holding shares in TSE:AMGN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S Stock Smart Score

Neutral

News Sentiment

Very Bullish

Bullish news 100%
Bearish news 0%

Fundamentals

Return on Equity

2.54%

Trailing 12-Months

Asset Growth

13.13%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.